Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Pharmacology|September 3, 2018
Inhibition of Rho kinase by GSK 269962 reverses both corticosterone-induced detrusor overactivity and depression-like behaviour in ratsAndrzej Wróbel, Anna Serefko, Ewa Rechberger, et al.
Biomed Research International|May 13, 2017
Antimicrobial Resistance Patterns in Women with Positive Urine Culture: Does Menopausal Status Make a Significant Difference?Pawel Miotla, Katarzyna Romanek-Piva, Michal Bogusiewicz, et al.
Neurourology and Urodynamics|January 16, 2019
Long-term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II studyElizabeth R Mueller, Rob van Maanen, Christopher Chapple, et al.
Ginekologia Polska|March 22, 2022
The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guideline for the diagnostic assessment of stress urinary incontinence in womenEdyta Wlazlak, Magdalena E Grzybowska, Tomasz Rechberger, et al.
Ginekologia Polska|April 12, 2021
The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guideline on the use of urodynamic testing in gynecological practiceArtur Rogowski, Bartosz Dybowski, Edyta Wlazlak, et al.
Ginekologia Polska|November 18, 2025
The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guideline on the diagnostic management of non-neurogenic overactive bladder syndrome in womenBartosz Dybowski, Elzbieta Narojczyk-Swiesciak, Wlodzimierz Baranowski, et al.
Ginekologia Polska|June 26, 2024
The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians Guidelines for the diagnostic assessment of pelvic organ prolapseEdyta Wlazlak, Tomasz Kluz, Tomasz Rechberger, et al.
European Urology|June 6, 2018
Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)Christian Gratzke, Rob van Maanen, Christopher Chapple, et al.
Contemporary Clinical Trials|February 11, 2017
Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroidsChristian Seitz, Žana Bumbuliene, Ana Rosa Costa, et al.
Ginekologia Polska|March 4, 2011
[Risk factors of pelvic organ prolapsed in women qualified to reconstructive surgery--the Polish multicenter study]Tomasz Rechberger, Paweł Miotła, Konrad Futyma, et al.
Pageof 22